🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’re pleased to share the #CML ‘papers of the month’ as selected by Professor Timothy Hughes. Professor Hughes’ selection of relevant CML papers published in June can be found on our website bit.ly/3MQuSis

Good data on Evusheld protection from a study from israel. Protective to avoid infection. Very protective to avoid hospitalization

Christopher Sharp @evusheld4theuk Blood Cancer UK Kidney Research UK Kidney Care UK @kidneycareuk.bsky.social Thank you so much for your support. @evusheld4theuk we really appreciate this on behalf of those we represent. A solution for us to live our luves and a solution to ease the pressure on the NHS to free beds and resources for over patienrs this winter

Christopher Sharp @evusheld4theuk Blood Cancer UK Kidney Research UK Kidney Care UK @kidneycareuk.bsky.social Sign/RT evusheld petition too: petition.parliament.uk/petitions/6118…

Thai vaccine study youtu.be/ekTR0w2M9-U via YouTube

Have questions only #CML experts can answer? Join our ‘Meet the CML Expert’ iCMLf virtual Conversation September 21! Professors Jane Apperley & Giuseppe Saglio will provide insights into CML cases, research & management at 2pm CEST. More info bit.ly/3SXGJiw

Had a patient present with Ophthalmologic manifestations upon #CML diagnosis? We recommend viewing our latest Presentation in Module 5 of the iCMLf Knowledge Centre ‘Managing Comorbidities - Ophthalmologic manifestations’ to better understand this, here bit.ly/3AynFPz

orthomolecular.activehosted.com/index.php?acti…

Submit your questions in advance to the upcoming 'Meet the CML Experts' iCMLf Conversation on 21/9/22 at 2pm CEST. Ask your CML-related questions to Professors Jane Apperley & Giuseppe Saglio to get their opinions and expertise. Find out more here: bit.ly/3B41ReA

We’re pleased to share the #CML ‘papers of the month’ as selected by Professor Timothy Hughes. Professor Hughes’ selection of relevant CML papers published in September can be found on our website here: bit.ly/3RnEDXz

Join us October 26 2PM CEST for our next iCMLf Conversation from the 24th John Goldman Conference. Listen as Professors Jorge Cortes & Daniela Krauseus provide an overview of the clinical & biological aspects presented at the conference. More information: bit.ly/3e7I3Q8

Did you miss our latest iCMLf Conversation: 'Meet the #CML Expert' with Professors Jane Apperley and Giuseppe Saglio? It's now available to view online! Watch and listen as they discuss important topics and answer relevant questions relating to CML bit.ly/3W7vgP4

New Boston virus youtu.be/_WTZo9ieBKY via YouTube

Why is strep A surging — and how worried are scientists? nature.com/articles/d4158…

Superb interview by Dr Julia Grace Patterson💙 …

Today we show our support to all cancer patients as part of World Cancer Day. A day dedicated to raising awareness & working together to create a world where preventable cancer deaths are stopped & life-saving cancer treatment & care is accessible for all global citizens.

Is Aspirin the target of a discrediting campaign? For decades, a daily regimen of low-dose so-called “baby aspirin” (81milligrams), was recommended to prevent and treat heart attack, stroke and angina (chest pain) in those 50 and older. That began to change in 2014, when the

we just joined the Huberman Lab Neural Network Newsletter hubermanlab.com/neural-network/ via Andrew D. Huberman, Ph.D.

Join our iCMLf Conversation ‘CML EHA Highlights’ & hear Professor Andreas Hochhaus share insights from his presentation Late line treatment in chronic phase & key clinical CML highlights from the congress. Join us July 12 & hear from a renowned CML expert: bit.ly/3JN3Nh0

"Should patients switch TKIs periodically to reduce toxicity impact?” Watch as CML experts Professors Tim Hughes & Jeff Lipton answered this and other #CML management questions during our latest iCMLf Conversation: bit.ly/3riJjX4